Clinical Trial Update: Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Nimotuzumab in combination with AG for pancreatic cancer with liver metastasis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AG
• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN